Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: Andrew H who wrote (337)	6/12/1998 11:53:00 AM
From: justaninvestor	Read Replies (2) \| Respond to of 5402

Didn't macker just say this? <they got through A and A prime but never though B or B prime before they got bought by baxter> I don't know the history of this company, but isn't macker only saying that they didn't get to phase 2 BEFORE they got bought out, not that they NEVER got to phase 2. bbruin -"HLBS&DW"

To: Andrew H who wrote (337)	6/12/1998 11:55:00 AM
From: drdan	Read Replies (1) \| Respond to of 5402

Can anyone tell me at what point in testing was smtg bought out?

To: Andrew H who wrote (337)	6/12/1998 12:00:00 PM
From: macker	Read Replies (1) \| Respond to of 5402

exactly pre-fda, but not fda phase 1, big difference. they will not even be filing for fda approval for a while unless baxter pulls some strings for them. there are different phases within each phase as well, there is A and A prime, B and B prime which is considered phase 1 and 2 within each phase. this is confusing to many and is what also caused a lot of stockholder upset in january when holders had it explained to them, the confusion over pre-fda clinical phases and fda clinical phases obviously still exists, the 10 k confused many. also the phase 2 trials were not conclusive and they had to get more data and enroll more patients so phase 2 has not even been completed. macker